Emerald Health Pharmaceuticals Inc. — Regulation A 1-A/A

Emerald Health Pharmaceuticals Inc. of San Diego, CA filed a Regulation A 1-A/A with the SEC on 2019-05-15. Aggregate offering: $50.0M (Tier 2). Industry: Other.

Offering

Filed: 2019-05-15
Form: 1-A/A
Accession: 0001213900-19-008902
Tier: Tier 2
Total aggregate offering: $50.0M
Issuer portion: $37.3M
Price per security: $6.0000
Securities offered: Equity (common or preferred stock)
Audit status: Audited
Auditor: Deloitte & Touche LLP
Jurisdictions: 64 states/territories

Issuer

CIK: 0001700800
Organized in: DE
Incorporated: 2017
Address: 5910 Pacific Center Blvd, San Diego, CA, 92121
Phone: 858-352-0622
Employees: 15 full-time

Financial snapshot (as filed)

Total assets: $1.2M
Cash & equivalents: $138K
Total liabilities: $12.0M
Stockholder equity: $-10.7M
Net income: $-8.4M

People (2)

Name	Role	Location
Jill Broadfoot	Signer	Hayward, CA
Lisa Sanford	Signer	San Diego, CA

Other Reg A filings by this issuer (17)

Showing 15 of 17 filings.

Filed	Form
2022-04-29	1-K
2021-10-06	1-A/A
2021-07-26	1-A
2021-04-30	1-K
2020-11-23	1-A POS
2020-11-06	1-A POS
2020-07-10	1-A POS
2020-06-15	1-A POS
2020-04-28	1-K
2019-05-30	1-A POS
2019-05-20	1-A POS
2019-04-23	1-K
2019-03-29	1-A POS
2018-07-23	1-K
2018-03-27	1-A/A

More